Lv1
40 积分 2025-02-18 加入
Lipid metabolism in T cell signaling and function
2天前
已完结
Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): First results of the CheckMate 8HW study
2天前
已关闭
皖公网安备34019202002308
